Population-based utilization of radiation therapy by a Canadian breast cancer cohort

N. Mittmann, S. J. Seung, N. Mittmann, N. Mittmann, J. S. Hoch, N. Liu, J. Porter, R. Saskin, C. C. Earle, Jeffrey S Hoch, W. K. Evans, N. B. Leighl, M. Trudeau, C. C. Earle

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We examined trends in radiation therapy (rt) utilization by a population-based breast cancer cohort in Ontario. The provincial cancer registry provided a breast cancer cohort based on diagnosis dates from April 1, 2005, to March 31, 2010. Staging information was also available. The cohort was then linked, by encrypted health card number, to linkable administrative datasets, including rt utilization.

The average age in the identified female breast cancer cohort (n = 39,656) was 61.6 ± 14.0 years. Almost two thirds of the patients (n = 25,225) received rt, and staging information was available for 22,988 patients (9541 stage i, 8516 stage ii, 4050 stage iii, and 881 stage iv). The average number of rt courses received by the patients was 1.4 ± 0.7 for stage i, 1.8 ± 1.1 for stage ii, 2.5 ± 1.3 for stage iii, and 2.8 ± 2.4 for stage iv. The ratio of conventional rt to intensity-modulated rt was 70.9%:16.6% for stage i, 71.6%:11.3% for stage ii, 74.6%:4.6% for stage iii, and 89.6%:2.2% for stage iv.

From 2005 to 2010, almost two thirds of a Canadian female breast cancer cohort received rt, and the average number of courses increased with disease severity. A similar trend was observed with the type of rt (use of conventional rt increased with disease severity). The next step is to apply unit costs to the number of fractions and to obtain rt planning and radiation therapist times.

Original languageEnglish (US)
Pages (from-to)e715-e717
JournalCurrent Oncology
Volume21
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Radiotherapy
Breast Neoplasms
Population
Ontario
Registries
Radiation
Costs and Cost Analysis
Health
Neoplasms

Keywords

  • Breast cancer
  • Radiation
  • Utilization

ASJC Scopus subject areas

  • Oncology

Cite this

Mittmann, N., Seung, S. J., Mittmann, N., Mittmann, N., Hoch, J. S., Liu, N., ... Earle, C. C. (2014). Population-based utilization of radiation therapy by a Canadian breast cancer cohort. Current Oncology, 21(5), e715-e717. https://doi.org/10.3747/co.21.2162

Population-based utilization of radiation therapy by a Canadian breast cancer cohort. / Mittmann, N.; Seung, S. J.; Mittmann, N.; Mittmann, N.; Hoch, J. S.; Liu, N.; Porter, J.; Saskin, R.; Earle, C. C.; Hoch, Jeffrey S; Evans, W. K.; Leighl, N. B.; Trudeau, M.; Earle, C. C.

In: Current Oncology, Vol. 21, No. 5, 2014, p. e715-e717.

Research output: Contribution to journalArticle

Mittmann, N, Seung, SJ, Mittmann, N, Mittmann, N, Hoch, JS, Liu, N, Porter, J, Saskin, R, Earle, CC, Hoch, JS, Evans, WK, Leighl, NB, Trudeau, M & Earle, CC 2014, 'Population-based utilization of radiation therapy by a Canadian breast cancer cohort', Current Oncology, vol. 21, no. 5, pp. e715-e717. https://doi.org/10.3747/co.21.2162
Mittmann N, Seung SJ, Mittmann N, Mittmann N, Hoch JS, Liu N et al. Population-based utilization of radiation therapy by a Canadian breast cancer cohort. Current Oncology. 2014;21(5):e715-e717. https://doi.org/10.3747/co.21.2162
Mittmann, N. ; Seung, S. J. ; Mittmann, N. ; Mittmann, N. ; Hoch, J. S. ; Liu, N. ; Porter, J. ; Saskin, R. ; Earle, C. C. ; Hoch, Jeffrey S ; Evans, W. K. ; Leighl, N. B. ; Trudeau, M. ; Earle, C. C. / Population-based utilization of radiation therapy by a Canadian breast cancer cohort. In: Current Oncology. 2014 ; Vol. 21, No. 5. pp. e715-e717.
@article{11b7cde60ec948f083cf72e5bd9b2b90,
title = "Population-based utilization of radiation therapy by a Canadian breast cancer cohort",
abstract = "We examined trends in radiation therapy (rt) utilization by a population-based breast cancer cohort in Ontario. The provincial cancer registry provided a breast cancer cohort based on diagnosis dates from April 1, 2005, to March 31, 2010. Staging information was also available. The cohort was then linked, by encrypted health card number, to linkable administrative datasets, including rt utilization.The average age in the identified female breast cancer cohort (n = 39,656) was 61.6 ± 14.0 years. Almost two thirds of the patients (n = 25,225) received rt, and staging information was available for 22,988 patients (9541 stage i, 8516 stage ii, 4050 stage iii, and 881 stage iv). The average number of rt courses received by the patients was 1.4 ± 0.7 for stage i, 1.8 ± 1.1 for stage ii, 2.5 ± 1.3 for stage iii, and 2.8 ± 2.4 for stage iv. The ratio of conventional rt to intensity-modulated rt was 70.9{\%}:16.6{\%} for stage i, 71.6{\%}:11.3{\%} for stage ii, 74.6{\%}:4.6{\%} for stage iii, and 89.6{\%}:2.2{\%} for stage iv.From 2005 to 2010, almost two thirds of a Canadian female breast cancer cohort received rt, and the average number of courses increased with disease severity. A similar trend was observed with the type of rt (use of conventional rt increased with disease severity). The next step is to apply unit costs to the number of fractions and to obtain rt planning and radiation therapist times.",
keywords = "Breast cancer, Radiation, Utilization",
author = "N. Mittmann and Seung, {S. J.} and N. Mittmann and N. Mittmann and Hoch, {J. S.} and N. Liu and J. Porter and R. Saskin and Earle, {C. C.} and Hoch, {Jeffrey S} and Evans, {W. K.} and Leighl, {N. B.} and M. Trudeau and Earle, {C. C.}",
year = "2014",
doi = "10.3747/co.21.2162",
language = "English (US)",
volume = "21",
pages = "e715--e717",
journal = "Current Oncology",
issn = "1198-0052",
publisher = "Multimed Inc.",
number = "5",

}

TY - JOUR

T1 - Population-based utilization of radiation therapy by a Canadian breast cancer cohort

AU - Mittmann, N.

AU - Seung, S. J.

AU - Mittmann, N.

AU - Mittmann, N.

AU - Hoch, J. S.

AU - Liu, N.

AU - Porter, J.

AU - Saskin, R.

AU - Earle, C. C.

AU - Hoch, Jeffrey S

AU - Evans, W. K.

AU - Leighl, N. B.

AU - Trudeau, M.

AU - Earle, C. C.

PY - 2014

Y1 - 2014

N2 - We examined trends in radiation therapy (rt) utilization by a population-based breast cancer cohort in Ontario. The provincial cancer registry provided a breast cancer cohort based on diagnosis dates from April 1, 2005, to March 31, 2010. Staging information was also available. The cohort was then linked, by encrypted health card number, to linkable administrative datasets, including rt utilization.The average age in the identified female breast cancer cohort (n = 39,656) was 61.6 ± 14.0 years. Almost two thirds of the patients (n = 25,225) received rt, and staging information was available for 22,988 patients (9541 stage i, 8516 stage ii, 4050 stage iii, and 881 stage iv). The average number of rt courses received by the patients was 1.4 ± 0.7 for stage i, 1.8 ± 1.1 for stage ii, 2.5 ± 1.3 for stage iii, and 2.8 ± 2.4 for stage iv. The ratio of conventional rt to intensity-modulated rt was 70.9%:16.6% for stage i, 71.6%:11.3% for stage ii, 74.6%:4.6% for stage iii, and 89.6%:2.2% for stage iv.From 2005 to 2010, almost two thirds of a Canadian female breast cancer cohort received rt, and the average number of courses increased with disease severity. A similar trend was observed with the type of rt (use of conventional rt increased with disease severity). The next step is to apply unit costs to the number of fractions and to obtain rt planning and radiation therapist times.

AB - We examined trends in radiation therapy (rt) utilization by a population-based breast cancer cohort in Ontario. The provincial cancer registry provided a breast cancer cohort based on diagnosis dates from April 1, 2005, to March 31, 2010. Staging information was also available. The cohort was then linked, by encrypted health card number, to linkable administrative datasets, including rt utilization.The average age in the identified female breast cancer cohort (n = 39,656) was 61.6 ± 14.0 years. Almost two thirds of the patients (n = 25,225) received rt, and staging information was available for 22,988 patients (9541 stage i, 8516 stage ii, 4050 stage iii, and 881 stage iv). The average number of rt courses received by the patients was 1.4 ± 0.7 for stage i, 1.8 ± 1.1 for stage ii, 2.5 ± 1.3 for stage iii, and 2.8 ± 2.4 for stage iv. The ratio of conventional rt to intensity-modulated rt was 70.9%:16.6% for stage i, 71.6%:11.3% for stage ii, 74.6%:4.6% for stage iii, and 89.6%:2.2% for stage iv.From 2005 to 2010, almost two thirds of a Canadian female breast cancer cohort received rt, and the average number of courses increased with disease severity. A similar trend was observed with the type of rt (use of conventional rt increased with disease severity). The next step is to apply unit costs to the number of fractions and to obtain rt planning and radiation therapist times.

KW - Breast cancer

KW - Radiation

KW - Utilization

UR - http://www.scopus.com/inward/record.url?scp=84907805925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907805925&partnerID=8YFLogxK

U2 - 10.3747/co.21.2162

DO - 10.3747/co.21.2162

M3 - Article

AN - SCOPUS:84907805925

VL - 21

SP - e715-e717

JO - Current Oncology

JF - Current Oncology

SN - 1198-0052

IS - 5

ER -